Next Article in Journal
MiR-122 Induces Radiosensitization in Non-Small Cell Lung Cancer Cell Line
Next Article in Special Issue
The Effect of Coatings on the Affinity of Lanthanide Nanoparticles to MKN45 and HeLa Cancer Cells and Improvement in Photodynamic Therapy Efficiency
Previous Article in Journal
Maternal PUFA ω-3 Supplementation Prevents Neonatal Lung Injuries Induced by Hyperoxia in Newborn Rats
Previous Article in Special Issue
Optimization and Evaluation of a Chitosan/Hydroxypropyl Methylcellulose Hydrogel Containing Toluidine Blue O for Antimicrobial Photodynamic Inactivation

Drug Carrier for Photodynamic Cancer Therapy

Graduate Institute of Applied Science and Technology, National Taiwan University of Science and Technology, 106 Taipei, Taiwan
Department of Chemical Engineering, National Tsing Hua University, 300 Hsinchu, Taiwan
Author to whom correspondence should be addressed.
Academic Editors: Michael R. Hamblin and Ying-ying Huang
Int. J. Mol. Sci. 2015, 16(9), 22094-22136;
Received: 30 July 2015 / Revised: 17 August 2015 / Accepted: 20 August 2015 / Published: 14 September 2015
(This article belongs to the Special Issue Advances in Photodynamic Therapy)
Photodynamic therapy (PDT) is a non-invasive combinatorial therapeutic modality using light, photosensitizer (PS), and oxygen used for the treatment of cancer and other diseases. When PSs in cells are exposed to specific wavelengths of light, they are transformed from the singlet ground state (S0) to an excited singlet state (S1–Sn), followed by intersystem crossing to an excited triplet state (T1). The energy transferred from T1 to biological substrates and molecular oxygen, via type I and II reactions, generates reactive oxygen species, (1O2, H2O2, O2*, HO*), which causes cellular damage that leads to tumor cell death through necrosis or apoptosis. The solubility, selectivity, and targeting of photosensitizers are important factors that must be considered in PDT. Nano-formulating PSs with organic and inorganic nanoparticles poses as potential strategy to satisfy the requirements of an ideal PDT system. In this review, we summarize several organic and inorganic PS carriers that have been studied to enhance the efficacy of photodynamic therapy against cancer. View Full-Text
Keywords: photodynamic therapy; photosensitizers; cancer cells; nanoparticles; biodegradable; organic nanocarrier; inorganic nanocarrier photodynamic therapy; photosensitizers; cancer cells; nanoparticles; biodegradable; organic nanocarrier; inorganic nanocarrier
Show Figures

Figure 1

MDPI and ACS Style

Debele, T.A.; Peng, S.; Tsai, H.-C. Drug Carrier for Photodynamic Cancer Therapy. Int. J. Mol. Sci. 2015, 16, 22094-22136.

AMA Style

Debele TA, Peng S, Tsai H-C. Drug Carrier for Photodynamic Cancer Therapy. International Journal of Molecular Sciences. 2015; 16(9):22094-22136.

Chicago/Turabian Style

Debele, Tilahun A., Sydney Peng, and Hsieh-Chih Tsai. 2015. "Drug Carrier for Photodynamic Cancer Therapy" International Journal of Molecular Sciences 16, no. 9: 22094-22136.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop